Gyeonggi-do, South Korea

Ki Seok Park




Average Co-Inventor Count = 9.1

ph-index = 1


Location History:

  • Gyeonggi-do, KR (2022)
  • Siheung-si, KR (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ki Seok Park in Pharmaceutical Development

Introduction

Ki Seok Park, a prominent inventor located in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he has focused on innovations aimed at improving treatment methods for various health conditions. His notable work primarily revolves around the prevention and treatment of dry eye syndrome and enhancements in drug absorption.

Latest Patents

Ki Seok Park's latest patents include groundbreaking formulations and methods. The first patent describes an oral pharmaceutical composition for preventing or treating dry eye syndrome, which incorporates rebamipide or a prodrug thereof as an active ingredient. This innovative composition allows for the treatment of dry eye syndrome via the oral route, offering a safer and more convenient alternative to conventional eye drops.

The second patent presents a novel rebamipide prodrug, which significantly enhances absorption rates—an increase of 25-fold compared to the original rebamipide compound. This prodrug can be utilized for the prevention and therapy of several conditions, including gastric ulcers, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, and obesity.

Career Highlights

Throughout his career, Ki Seok Park has worked with respected organizations such as Samjin Pharmaceutical Co., Ltd. and Astech Co., Ltd., contributing to the advancement of pharmaceutical innovations. His experience within these companies has been instrumental in his development of new therapeutic solutions.

Collaborations

Ki Seok Park has collaborated with notable professionals in the industry, including Eui Hwan Cho and Sung Ju Choi. These partnerships have fostered a creative environment that encourages innovation and enhances the potential for impactful medical advancements.

Conclusion

Ki Seok Park's contributions to pharmaceutical development reflect his commitment to enhancing patient care through innovative treatments. His patents signify a transformative approach to addressing pharmaceutical challenges, particularly in delivering effective therapies through oral administration. As he continues to expand his research, the pharmaceutical industry eagerly anticipates the potential benefits of his groundbreaking work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…